According to our results from comparing two regimens and performing a ranking analysis, we found that PARPi + Platinum + Chemo therapy might be the best regimen for HER2-negative BC patients, regardless of whether they are TNBC or HR-positive. The gene discussed is ERBB2; the disease is breast cancer.